The Efficacy of Acupuncture as a Complementary Treatment for Pain and Anxiety After Breast Cancer Surgery
2 other identifiers
interventional
40
0 countries
N/A
Brief Summary
Background: Breast cancer is one of the most prevalent cancers worldwide. Fortunately, survival has improved in recent years thanks to its early detection and curative treatments such as mastectomy. However, this medical procedure is associated with a range of unwanted effects such as postoperative pain and anxiety. Some studies have reported that acupuncture could be an effective treatment to control these types of symptoms, although only few studies have been conducted on women undergoing mastectomy. Methods: This is a pragmatic randomized controlled trial with blind assessors. The study will be conducted in the Breast Unit of Hospital Universitario Sagrado Corazon of Barcelona (Spain). A sample of 40 women will be recruited and randomized to receive acupuncture treatment in addition to standard care procedures, or standard care procedures alone. The main outcome, pain, will be assessed after the surgical intervention and 4, 10 and 30 days later using the numerical rating scale. Secondary outcomes include anxiety, use of analgesics, nausea, adverse effects, and surgical complications. Discussion: Acupuncture is a low-cost non-pharmacological strategy. This study will help to clarify its possible role in controlling post-mastectomy adverse effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2020
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2020
CompletedFirst Posted
Study publicly available on registry
October 29, 2020
CompletedStudy Start
First participant enrolled
November 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedOctober 29, 2020
September 1, 2020
2 years
October 9, 2020
October 27, 2020
Conditions
Outcome Measures
Primary Outcomes (5)
Post-intervention pain at 12 hours after surgery
Pain will be evaluated using the numerical rating scale (NRS). This measure uses a scale of 0 to 10 in which the higher values represent the most severe pain.
12 hours after surgery (before the acupuncture treatment)
Post-intervention pain at 48 hours after surgery
Pain will be evaluated using the numerical rating scale (NRS). This measure uses a scale of 0 to 10 in which the higher values represent the most severe pain.
48 hours after surgery (after the acupuncture treatment)
Post-intervention pain at first out-patient visit
Pain will be evaluated using the numerical rating scale (NRS). This measure uses a scale of 0 to 10 in which the higher values represent the most severe pain.
In the first out-patient visit between 10 and 12 days after the intervention (evaluated before the acupuncture session)
Analgesic compsumption during hospital stay
Amount of analgesic medication administered (ex: mg)
During the hospital stay
Analgesic compsumption at home
Amount of analgesic medication administered (ex: mg)
From discharge until day 15 after surgery.
Secondary Outcomes (8)
Anxiety at 12 hours
Evaluations will be made 12 hours after the intervention
Anxiety at 48 hours
Evaluations will be made 48 hours after the intervention
Anxiety at first visit
Evaluations will be made at first visit, between 10 and 12 days after the intervention.
Anxiety at one month
Evaluations will be made at one month after surgery.
Postoperative nausea after surgery
At 12 hours after surgery
- +3 more secondary outcomes
Study Arms (2)
Acupuncture group
EXPERIMENTALThe experimental group will receive the standard treatment administered in these cases (analgesic regimen and nursing care procedures), in addition to the following acupuncture therapy. In the first visit (preoperative), the anamnesis and energy diagnosis of each patient will be carried out following the practices of Traditional Chinese Medicine (TCM) to design a personalized treatment based on the patient's medical history. A treatment of approximately 10 to 12 acupuncture points will be designed considering the TCM diagnosis and medical history of each patient. Both TCM diagnosis and the points used will be reassessed in each session. The points belonging to the upper extremity of the affected breast will be treated on the contralateral side, taking care not to insert any needle in the limb on the affected side. No points in the operated region will be used.
Control group
NO INTERVENTIONThe control group will only receive standard care procedures (analgesic regimen and nursing care procedures), although they will have the same follow up visits as the patients in the intervention group to facilitate analysis of the study variables.
Interventions
Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. It is sometimes used in conjunction with heat, moxibustion, acupressure, or electric stimulation.
Eligibility Criteria
You may qualify if:
- Diagnosis of breast cancer
- Primary breast cancer patient
- Candidate for breast cancer surgery (mastectomy)
- Aged between 20 and 70 years old
- Consenting to participate in the study and signing the informed consent form.
You may not qualify if:
- Have a previous history of breast cancer
- Have a previous diagnosis of a severe psychiatric disorder
- Present risk factors associated with breast cancer
- Do not speak Spanish or Catalan
- Are currently participating in another trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ramon Llulllead
- Hospital Quiron Sagrado Corazoncollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 9, 2020
First Posted
October 29, 2020
Study Start
November 1, 2020
Primary Completion
November 1, 2022
Study Completion
March 1, 2023
Last Updated
October 29, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share